Concepedia

Stephanie Zhao

SZ

Statistics

Publications

6

Citations

506

H-Index

6

Active since

2015

Affiliations

Harvard University(Current)

Huazhong University of Science and Technology

Dana-Farber Cancer Institute

Washington University in St. Louis

Union Hospital

Stephanie Zhao is an author at Harvard University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2015–2024

6

Publications

6

Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism

Rong Wang, Zhen Yu, Bharath Sunchu et al. · Aging Cell · 2017 · 334 citations · Full text

, , +22

Clonal Hematopoiesis and Risk of Incident Lung Cancer

Ruiyi Tian, Brian Wiley, Jie Liu et al. · Journal of Clinical Oncology · 2022 · 72 citations · Full text

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth

Aarthi Kannan, Zhenyu Lin, Qiang Shao et al. · Oncotarget · 2015 · 40 citations · Full text

, , +12

Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts

Bin Fang, Aarthi Kannan, Stephanie Zhao et al. · Scientific Reports · 2020 · 27 citations · Full text

Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies

Marie-Anne Goyette, Laura E. Stevens, Carolyn R. DePinho et al. · Proceedings of the National Academy of Sciences · 2024 · 22 citations · Full text

, , +15

1–5 of 6